<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02894866</url>
  </required_header>
  <id_info>
    <org_study_id>NFEC-2016-097</org_study_id>
    <nct_id>NCT02894866</nct_id>
  </id_info>
  <brief_title>Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy</brief_title>
  <official_title>Effect of Hyperbaric Oxygen Therapy on Neonatal Hypoxic-Ischemic Encephalopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to to evaluate the safety and efficacy of hyperbaric oxygen in
      term gestation newborn infants with hypoxic-ischemic encephalopathy..
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypoxic-ischemic encephalopathy (HIE) remains a major cause of neonatal death and long term
      disabilities. Data from animal studies have shown protective effects of hyperbaric oxygen
      therapy to impaired brain. Recently research priorities have moved from bench to bedside.
      Several studies have shown a trend for brain protection of hyperbaric oxygen therapy has
      emerged as a promising treatment for HIE. Therefore,the investigators organized a
      multi-centered randomized controlled trial of hyperbaric oxygen therapy in HIE newborn
      infants.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Death or Moderate to Severe Disability Which is Graded According to Gross Motor Function Classification System （GMFCS）</measure>
    <time_frame>18 months of life</time_frame>
    <description>Number of Death or Moderate to Severe Disability Which is Graded According to</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Infants with abnormal ambulatory electroencephalography monitoring Abnormalities</measure>
    <time_frame>3 months of life</time_frame>
    <description>Number of Infants with abnormal ambulatory electroencephalography monitoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Infants with Brain Magnetic Resonance Imaging Abnormalities</measure>
    <time_frame>3 months of Lif</time_frame>
    <description>Number of Infants with Brain Magnetic Resonance Imaging Abnormalities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Infants with Brain-stem Auditory Evoked Potentials Abnormalities at 3 Months of Life</measure>
    <time_frame>3 months of life</time_frame>
    <description>Number of Infants with Brain-stem Auditory Evoked Potentials</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>neonatal behavioral neurological assessment</measure>
    <time_frame>7,14 and 28 days after birth</time_frame>
    <description>neonatal behavioral neurological assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bayley Scales of Infant Development</measure>
    <time_frame>6,12 and 18 months of life</time_frame>
    <description>Bayley Scales of Infant Development</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gross Motor Function Classification System</measure>
    <time_frame>18 months of life</time_frame>
    <description>Gross Motor Function Classification System</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events That Are Related to Treatment</measure>
    <time_frame>3 months of life</time_frame>
    <description>fundus examination by ophthalmofunduscope to evaluate retinopathy of prematurity，chest radiograph to evaluate pneumothorax, and monitoring vital signs by neonatal monitor</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Hypoxic-ischemic Encephalopathy</condition>
  <arm_group>
    <arm_group_label>hyperbaric oxygen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Newborns with hypoxic ischemic encephalopathy treated with intensive care and hyperbaric oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Newborns with hypoxic ischemic encephalopathy treated with intensive care only</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>hyperbaric oxygen</intervention_name>
    <description>The hyperbaric oxygen treatment will be administered for 60 min in a baby hyperbaric oxygen chamber pressured with 100% oxygen to 1.5 to 1.8 atm absolute (ATA) and a constant oxygen flow was given to maintain the oxygen. concentration in the chamber at 80% or greater.The treatment will be administered once a day within 7 days after birth, 7 days is a course of treatment, at least for 4 courses.</description>
    <arm_group_label>hyperbaric oxygen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

               -  Newborn infants whose gestational age ≥37 weeks' gestation, weighing over 2500 g
                  ;

               -  Acute perinatal event (e.g., late or variable decelerations, cord prolapse, cord
                  rupture, uterine rupture, maternal trauma, hemorrhage, or cardiorespiratory
                  arrest)

               -  With an Apgar score ≤ 3 at one minute and ≤5 at five minutes, and/or a potential
                  of hydrogen of 7.0 or less or a base deficit of 16 mmol per liter or more in a
                  sample of umbilical-cord blood or any blood during the first hour after birth.

               -  Having moderate-to-severe encephalopathy (indicated by lethargy, stupor, or coma)
                  and either hypotonia, abnormal reflexes (including oculomotor or pupillary
                  abnormalities), an absent or weak suck, or clinical seizures, and/or have
                  abnormal background activity of at least 20 minutes' duration or seizures on
                  amplitude integrated electroencephalography

          -  Exclusion Criteria:

               -  A congenital and the hereditary disease, a chromosome abnormalities, and a
                  congenital abnormality.

               -  During the acute phases of intracranial and (or) fundus hemorrhage. o

               -  Intracranial infection.

               -  Pneumothorax.

               -  Infants who have been received hypothermia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weimin Huang, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Nanfang Hospital of Southern Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lishan Guo, Doctor</last_name>
    <phone>+86 13580538496</phone>
    <email>nfyygls@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ming Yang, Master</last_name>
    <phone>+86 18933930186</phone>
    <email>ekym@vip.sina.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xiamen Maternity and Child Healthcare Hospital</name>
      <address>
        <city>Xiamen</city>
        <state>Fujian</state>
        <zip>361003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xingzhu Lin</last_name>
      <email>xinzhufj@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nanfang Hospital of Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lishan Guo, doctor</last_name>
      <phone>+86 13580538496</phone>
      <email>nfyygls@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiliang Cui</last_name>
      <phone>+86 13922705830</phone>
      <email>1551838354@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhujiang Hospital of Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510280</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Wang</last_name>
      <email>wangbin6556@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shenzhen Maternity and Child Healthcare Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chuanzhong Yang</last_name>
      <phone>+86 13500051711</phone>
      <email>13500051711@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shenzhen People's Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benqing Wu</last_name>
      <phone>+86 13902436593</phone>
      <email>wubenqing783@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Maternity and Child Healthcare Hospital of Guangxi Zhuang Autonomous Region</name>
      <address>
        <city>Guangxi</city>
        <state>Guangxi</state>
        <zip>530000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Qiufen Wei</last_name>
      <phone>+86 18077166317</phone>
      <email>Wqf915@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hunan Children's hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410007</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoming Peng</last_name>
      <email>pxmprf@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Jilin University</name>
      <address>
        <city>Jilin</city>
        <state>Jilin</state>
        <zip>130000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chaoying Yan</last_name>
      <phone>+86 13756661611</phone>
      <email>yanchaoying224@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chengdu Women and Children's central hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rong Ju</last_name>
      <phone>+86 18080103629</phone>
      <email>Jurong123@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2016</study_first_submitted>
  <study_first_submitted_qc>September 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2016</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypoxic-ischemic encephalopathy</keyword>
  <keyword>hyperbaric oxygen therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

